DJIA 17,148.45 16.48 0.10%
NASDAQ 4,558.39 5.63 0.12%
S&P 500 2,000.00 1.02 0.05%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

40.65 1.15 (2.91%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $40.65 2.91%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $39.62
Previous Close $39.50
Daily Range $39.21 - $40.87
52-Week Range $22.25 - $62.66
Market Cap $4.8B
P/E Ratio -48.77
Dividend (Yield) $0.00 (0.0%)
Volume 1,423,005
Average Daily Volume 2,042,802
Current FY EPS -$0.70





Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary Rss Feed

Why ISIS Pharmaceuticals Inc. Stock Is Flat in 2014

ISIS Pharmaceuticals shares have rebounded since spring, but still remain unchanged this year as investors digest a big stock move last year and wait for further proof that antisense RNA technology has blockbuster potential.

Isis Pharmaceuticals Earns $4M from Achaogen For The Initiation Of A Phase 3 Study Of Plazomicin

Why Anxious Investors' Pressure Could Push Small Cap Stocks Lower

Isis Pharmaceuticals (ISIS) Weak On High Volume Today

Jim Cramer's Top Stock Picks: TWTR TASR ACAD ISIS RH

Trade-Ideas: Isis Pharmaceuticals (ISIS) Is Today's Post-Market Leader Stock

October 31st Options Now Available For Isis Pharmaceuticals (ISIS)

'Mad Money' Lightning Round: Buy, Buy, Buy Flextronics

Notable ETF Inflow Detected - IWM, ISIS, GPK, ULTI

Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog

See More ISIS News...

ISIS's Top Competitors

ISIS $40.65 (2.91%)
Current stock: ISIS
AMGN $140.07 (0.53%)
Current stock: AMGN
GILD $102.76 (-1.91%)
Current stock: GILD
BIIB $325.05 (-0.56%)
Current stock: BIIB